MGC gets green light for cannabis dementia drug trial

PERTH: ASX listed biotech MGC Pharmaceuticals has secured a key approval from Australia’s Therapeutic Goods…

To read the full content…SUBSCRIBE NOW

Existing Subscribers Login Below:

Log In